Brief: Odonate Therapeutics Says Qtrly Loss Per Share of $1.15
24/07/2019 13:40
July 24 (Reuters) - Odonate Therapeutics Inc ODT.O :
* ODONATE THERAPEUTICS ANNOUNCES FINANCIAL RESULTS FOR THE
THREE
AND SIX MONTHS ENDED JUNE 30, 2019
* ODONATE THERAPEUTICS INC- QTRLY LOSS PER SHARE $1.15
* ODONATE THERAPEUTICS INC- CONTINUE TO EXPECT TO COMPLETE
ENROLLMENT IN CONTESSA IN H2 OF 2019 AND REPORT TOP-LINE RESULTS
IN 2020
Source text for Eikon: ID:nBwb5br0Pa
Further company coverage: ODT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Odonate
See all newsBrief: Odonate Announces Expected Delisting Of Its Stock
Brief: Odonate Therapeutics Announces Planned Return Of Capital To Stockholders Through Share Repurchase Plan
Brief: Odonate Therapeutics Announces Quarterly Loss Per Share Of $0.58
Odonate Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Odonate Therapeutics Inc expected to post a loss of 33 cents a share - Earnings Preview